CVS Health, Google Cloud to launch healthcare engagement platform / Beckers

Naomi Diaz / beckershospitalreview - CVS Health is partnering with Google Cloud to develop an AI-powered consumer engagement platform as part of a broader effort to reshape how patients interact with the healthcare system. In a March 5 news release, the company announced a partnership with G…

medicalxpress - A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.

#healthcare #biotech #digitalhealth #medicaldevices #oncology #pancreaticcancer

Startup Waiv Spins Out of Owkin With $33M to Bring AI Precision to Cancer Decisions

3 days / medcitynews / Frank Vinluan

An AI Driven Approach to Address the Non-Responder Gap in Radiopharmaceutical Therapy

4 days / medcitynews / Jayashri Pawar

'Closed-loop' AI clinical care is coming soon, startups predict

4 days / endpoints / Lydia Ramsey Pflanzer

Why This Rural Health System Is Scaling AI for Point-of-Care Decision Making

8 days / medcitynews / Katie Adams

New AI tool predicts best pancreatic cancer treatment

12 days / medicalxpress

Cedars-Sinai AI tool predicts best chemotherapy for pancreatic cancer patients

13 days / beckershospitalreview / Ella Jeffries

Saturday, March 7, 2026, 12:23 am / permalink 20310 / 6 stories in 9 days

FDA lifts hold on Intellia trial / Beckers

Ella Jeffries / beckershospitalreview - The FDA has lifted a clinical hold on Intellia Therapeutics’ phase 3 Magnitude trial of nexiguran ziclumeran, or nex-z. The trial was paused Oct. 29 after a patient developed grade 4 liver transaminase elevations and elevated bilirubin following a Sept. 3…

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda

Michael Gibson Discusses New Pathway for Approving Personalized Genetic Treatments

2 days / oncodaily

Keep up the momentum for gene therapies

4 days / nature

FDA lifts hold on Intellia trial

14 days / beckershospitalreview / Ella Jeffries

FDA lifts hold on second Intellia Phase 3 gene editing trial

14 days / endpoints / Lei Lei Wu

Saturday, March 7, 2026, 12:23 am / permalink 20309 / 4 stories in 9 days

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive

Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #healthcarefinance

It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?

8 days / medcitynews / Marissa Plescia

FTC seeing 'progress' in discussions with Optum, Caremark in insulin case

11 days / fiercehealthcare

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC

11 days / healthcaredive / Rebecca Pifer Parduhn

Saturday, March 7, 2026, 12:23 am / permalink 20308 / 3 stories in 9 days

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity

Frank Vinluan / medcitynews - Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna’s full financial payout to the companies is reache…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #healthcarefinance #infectiousdisease

Hung Trinh: Moderna Reaches $2.25B Settlement in mRNA Vaccine Patent Dispute

10 days / oncodaily

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology

12 days / medcitynews / Frank Vinluan

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

13 days / endpoints / Nicole DeFeudis

Saturday, March 7, 2026, 12:22 am / permalink 20307 / 3 stories in 9 days

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity

Frank Vinluan / medcitynews - Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in chi…

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment #oncology #healthcarefinance

Servier Acquires Day One Biopharmaceuticals for $2.5B, Betting on Tovorafenib and the Pediatric Glioma Frontier

4 days / oncodaily

Agreement with Day One Biopharmaceuticals to Expand Glioma Portfolio – Servier

9 days / oncodaily

Servier: A Caregiver’s Powerful Story on Rare Disease

9 days / oncodaily

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma

10 days / medcitynews / Frank Vinluan

Servier to buy Day One for $2.5B, gaining rare oncology medicines

10 days / endpoints / Kyle LaHucik

Saturday, March 7, 2026, 12:22 am / permalink 20306 / 5 stories in 9 days

FDA vaccine chief to step down in April / Beckers

Ella Jeffries / beckershospitalreview - Vinay Prasad, MD, the FDA’s top regulator of vaccines and cell and gene therapies, will step down at the end of April, an agency spokesperson confirmed to Becker’s. Dr. Prasad joined the agency in 2025 on a one-year sabbatical from the University of Calif…

#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety #infectiousdisease

FDA vaccine chief to step down in April

10 days / beckershospitalreview / Ella Jeffries

Divisive F.D.A. Vaccine Regulator Resigns

10 days / nytimes / Christina Jewett

Vinay Prasad to exit FDA again, following latest round of controversy

10 days / endpoints / Max Bayer

Friday, March 6, 2026, 6:23 pm / permalink 20292 / 3 stories in 10 days

Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive

Emily Olsen / healthcaredive - The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance

Judge dismisses Pennsylvania hospitals’ lawsuit over CVS’ 340B practices

10 days / beckershospitalreview / Ella Jeffries

Hospitals urge regulators to halt drugmakers’ expanded 340B data policies

11 days / healthcaredive / Emily Olsen

Higher heat stress leads to more cardiac ICU admissions, researchers find

12 days / medicalxpress

Hospitals decry drugmakers' expanded claims reporting policies for 340B

12 days / fiercehealthcare

Friday, March 6, 2026, 12:23 pm / permalink 20277 / 4 stories in 10 days

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people / Medical Express

medicalxpress - A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He didn't set a quit date. He simply lost interest. It happen…

#obesity #healthcare #pharmaceuticals #elililly #novonordisk #weightloss #publichealth #drugdevelopment #behavioralhealth

GLP-1 receptor agonists linked to lower mortality for patients with brain metastases, T2DM

3 days / medicalxpress

What happens after patients stop GLP-1s?

3 days / beckershospitalreview / Paige Twenter

AAOS: GLP-1 receptor agonist use increases five-year risk for osteoporosis

10 days / medicalxpress

Drugs Behind the Ozempic Weight-Loss Boom May Also Lower the Risk of Addiction

10 days / discovermagazine

Some patients keep weight off with fewer GLP-1 injections, study finds

10 days / medicalxpress

How do GLP-1 agonists affect gene expression?

10 days / medicalxpress

Eric Topol: GLP-1 Drugs Reduce Substance Abuse Risk in Over 600,000 US Veterans

10 days / oncodaily

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people

11 days / medicalxpress

GLP-1 drugs tied to lower addiction risk: Study

11 days / beckershospitalreview / Ella Jeffries

GLP‑1 drugs like Ozempic may lower the risk of addiction: New study

11 days / medicalxpress

Friday, March 6, 2026, 12:23 pm / permalink 20276 / 10 stories in 10 days

AI blood test finds silent liver disease years before symptoms / Science Daily Cancer

sciencedaily - Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wid…

#healthcare #publichealth #biotech #digitalhealth #medicaldevices #healthcarefinance

Karamvir Yadav on Transforming Breast Cancer Diagnosis with Fragmentomic Blood Tests

3 days / oncodaily

Uncovering a key signaling pathway linking liver cancer and fibrosis

3 days / medicalxpress

Ali Choukair Presents a 360° Approach to Metabolic Liver Disease – Emirates Digestive Diseases Week

9 days / oncodaily

ImmunoXXL Phase 2 Study: Liver Transplantation After Atezolizumab–Bevacizumab Downstaging in Advanced HCC

9 days / oncodaily

AI blood test finds silent liver disease years before symptoms

10 days / sciencedaily

AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals

12 days / medicalxpress

Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases

12 days / science / Akshaya V. Annapragada, Zachariah H. Foda, Hope Orjuela, Carter Norton, Shashikant Koul, Noushin Nik

Friday, March 6, 2026, 1:22 am / permalink 20251 / 7 stories in 10 days

Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy / LiveScience

livescience - An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #infanthealth

Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy

11 days / livescience

Drug breakthrough for children with severe form of epilepsy

12 days / bbc

First gene regulation clinical trials for epilepsy show promising results

12 days / medicalxpress

Life-changing drug identified for children with rare epilepsy

12 days / medicalxpress

Thursday, March 5, 2026, 4:23 pm / permalink 20233 / 4 stories in 11 days

Amazon launches Amazon Connect Health / Beckers

Naomi Diaz / beckershospitalreview - Amazon Web Services has launched Amazon Connect Health, an artificial intelligence tool designed to automate administrative tasks for health systems and improve patient access to care. Here are six things to know about Amazon Connect Health: Amazon Connec…

#healthcare #digitalhealth #hospitaloperations #healthcarefinance

New framework ensuring ethical and fair use of AI in health care

3 days / medicalxpress

Nurses navigate AI-generated health information at bedside

3 days / beckershospitalreview / Giles Bruce

Stanford Health Care leader to advise agentic AI startup

3 days / beckershospitalreview / Giles Bruce

Judge orders UnitedHealth to hand over documents in AI coverage denial case

3 days / beckershospitalreview / Jakob Emerson

CMS’ Oz envisions agentic AI in the hands of every Medicare beneficiary

3 days / beckershospitalreview / Elizabeth Casolo

Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members

3 days / fiercehealthcare

Microsoft unveils AI health tool that can read your medical records

3 days / medicalxpress

The buzz at HIMSS 2026: 6 notes

3 days / beckershospitalreview / Giles Bruce

Mount Sinai study: Multi-agent AI handles heavy clinical workloads better

3 days / beckershospitalreview / Naomi Diaz

Healthcare’s ‘AI tourism’ era is over: Columbia Business School

3 days / beckershospitalreview / Giles Bruce

UC Davis Health pilots AI scribe training for emergency medicine residents

3 days / beckershospitalreview / Naomi Diaz

CMS wants seniors to use AI for care navigation

3 days / healthcaredive / Emily Olsen

Screening with AI could cut unnecessary glaucoma referrals by half

3 days / medicalxpress

Computing power is no longer the AI bottleneck — it's energy production

3 days / livescience

Microsoft Enters Healthcare Chatbot Race with Copilot Health

4 days / medcitynews / Katie Adams

Richard Dirven Calls for Responsible Integration of AI in Precision Oncology Care

9 days / oncodaily

CVS, Humana & More Are Turning to Google’s AI Models

10 days / medcitynews / Katie Adams

Highmark Health generates $28M in value with Google AI

10 days / beckershospitalreview / Giles Bruce

Privacy Expectations in Consumer AI Tools: How Patient Use of ChatGPT Health and Claude Differs From HIPAA-Regulated Care

10 days / medcitynews / Nirmal Vemanna

How to use AI tools to support our wellbeing in safe and simple ways

10 days / bbc

Future of Health Tech: From Structured Data to Scalable AI [Video]

10 days / medcitynews / wlim

Salesforce partners with HealthEx, Verily and Viz.ai to build out healthcare AI agents

11 days / fiercehealthcare

Optum expands Microsoft collaboration to add AI to claims platform

11 days / beckershospitalreview / Naomi Diaz

4 health system leaders join initiative to improve patient safety with AI

11 days / beckershospitalreview / Giles Bruce

AI Startups Are Tying Fees to Completed Tasks. Will Hospitals Buy In?

11 days / medcitynews / Katie Adams

Microsoft unveils new Dragon Copilot AI capabilities for clinicians

11 days / beckershospitalreview / Naomi Diaz

Optum teams with Microsoft to expand AI-powered claims platform

11 days / fiercehealthcare

Waystar expanding Google Cloud collaboration

11 days / beckershospitalreview / Andrew Cass

The algorithm will see you now? Patients say not without a doctor nearby

11 days / medicalxpress

Amazon launches Amazon Connect Health

11 days / beckershospitalreview / Naomi Diaz

Amazon launches suite of healthcare AI agents

11 days / healthcaredive / Emily Olsen

When Artificial Intelligence Starts Rewriting Reality

11 days / thehealthcareblog / matthew holt

AWS offers agentic AI solution to tackle scheduling, ambient note-taking and medical coding

11 days / fiercehealthcare

Thursday, March 5, 2026, 11:23 am / permalink 20205 / 33 stories in 11 days

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent Prostate Cancer and PSA of 0.5 ng/mL or Less / ESMO

esmo - Findings from the POSEIDON meta-analysis of the MARCAP consortium

#healthcare #pharmaceuticals #publichealth #oncology

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent Prostate Cancer and PSA of 0.5 ng/mL or Less

11 days / esmo

Majid Al Othman: POSEIDON Meta-Analysis Results in Post-Prostatectomy Salvage RT

15 days / oncodaily

Sault skiiers bring home medals from youth championships

17 days / sootoday

Thursday, March 5, 2026, 3:23 am / permalink 20175 / 3 stories in 11 days

Novo Nordisk inks $2.1B oral obesity drug deal / Beckers

Ella Jeffries / beckershospitalreview - Novo Nordisk has partnered with Vivtex Corp. to develop next-generation oral biologic medicines for obesity, diabetes and related conditions. Under the agreement, Vivtex will license its proprietary oral drug-delivery technologies to Novo Nordisk and is e…

#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #biotech #drugdevelopment #healthcarefinance

Gubra plots Roivant-like model as partnered obesity drugs take flight

3 days / endpoints / Kyle LaHucik

Pfizer gets obesity drug approval in China shortly after buying local rights

10 days / endpoints / Elizabeth Cairns

Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity

11 days / medicalxpress

Roche partner Zealand posts Phase 2 data for amylin obesity drug

11 days / endpoints / Kyle LaHucik

Novo Nordisk details Irish expansion; EuroAPI’s challenges continue

11 days / endpoints / Anna Brown

What to know about how GLP-1 medications might fight addiction

11 days / medicalxpress

Twenty percent of eligible youth prescribed GLP-1 receptor agonists

12 days / medicalxpress

GLP-1 medications get at the heart of addiction, study finds

12 days / medicalxpress

Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last

12 days / medicalxpress

Eli Lilly launches its direct-to-employer platform for obesity drugs

12 days / fiercehealthcare

Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds

12 days / nytimes / Roni Caryn Rabin

AHA urges HHS to block Novo Nordisk’s 340B data demand

12 days / beckershospitalreview / Paige Twenter

FDA sends Novo Nordisk 2nd warning over GLP-1 ads

12 days / beckershospitalreview / Erica Cerutti

How gut bacteria and diet can reprogram fat to burn more energy

12 days / medicalxpress

No more weekly injections? How lettuce cells could deliver GLP-1 pills

12 days / medicalxpress

GLP-1 weight-loss drugs comparably effective across age, race and starting weight

12 days / medicalxpress

FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters

13 days / fiercehealthcare

FDA warns 30 telehealth firms over compounded GLP-1 claims

13 days / beckershospitalreview / Ella Jeffries

Hims partner Strive Pharmacy will reintroduce GLP-1 pill pulled from market

13 days / endpoints / Shelby Livingston

Novo Nordisk inks $2.1B oral obesity drug deal

14 days / beckershospitalreview / Ella Jeffries

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

19 days / medcitynews / Frank Vinluan

Novo Nordisk teams with Langer-founded biotech for oral obesity drugs

19 days / endpoints / Kyle LaHucik

Tuesday, March 3, 2026, 1:22 am / permalink 20039 / 22 stories in 13 days

RFK Jr. names 2 new members to CDC vaccine panel / Beckers

Erica Cerutti / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. appointed two new members to the CDC’s vaccine advisory committee Feb. 27, ahead of a rescheduled meeting in mid-March where members are expected to review COVID-19 vaccine recommendations. Mr. Kennedy said Sean Downing…

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #infectiousdisease

Doctors Warn of a Deadly Complication From Measles Outbreaks

3 days / kffhealthnews / Rae Ellen Bichell

HHS strikes deal with 53 medical schools to expand nutrition training

11 days / beckershospitalreview / Erica Cerutti

Dozens of medical schools meet RFK Jr.'s call for greater nutrition education

11 days / fiercehealthcare

Minnesota sues feds over nearly $244M in frozen Medicaid funds

12 days / beckershospitalreview / Elizabeth Casolo

In South Carolina Measles Outbreak, Vaccine Skepticism Led to Largest Outbreak Since 2000

13 days / nytimes / Anemona Hartocollis and Kaoly Gutierrez

U.S. tops 1,100 measles cases this year as outbreaks grow

14 days / medicalxpress

Two more members added to ACIP ahead of March meeting

14 days / endpoints / Max Bayer

Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting

14 days / fiercehealthcare

RFK Jr. names 2 new members to CDC vaccine panel

14 days / beckershospitalreview / Erica Cerutti

Monday, March 2, 2026, 3:24 pm / permalink 20024 / 9 stories in 14 days

Parents of gravely ill child refused respite care / BBC

bbc - Birmingham Children's Trust refused respite help and suggested training grandparents to help.

#healthcare #publichealth #governmentpolicy #behavioralhealth

'Moment of reckoning' needed in social care, says Louise Casey

11 days / bbc

Trying to get social care can be 'horrendous', Baroness Casey tells BBC

11 days / bbc

Families Defend Disability Services Amid Medicaid Cuts

14 days / kffhealthnews / Bram Sable-Smith

E-biking boosts health, physical activity levels, study finds

17 days / medicalxpress

Parents of gravely ill child refused respite care

17 days / bbc

Monday, March 2, 2026, 2:22 am / permalink 19974 / 5 stories in 14 days

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours / ESMO

esmo - Findings from the PYNNACLE study

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology

Mohamed Emam Sobeih Explores Rezatapopt Activity in TP53 Y220C-Mutated Solid Tumors

3 days / oncodaily

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

13 days / oncodaily

Targeting the untargetable cancer—rezatapopt, an oral p53 reactivator

14 days / medicalxpress

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours

14 days / esmo

Jayastu Senapati: Trial of Rezatapopt in TP53-Y220C Mutated MDS/AML

15 days / oncodaily

Rashid Lui: First-in-Class Oral Selective p53 Reactivator Looks Promising

17 days / oncodaily

Xin Lu on Targeting Mutant p53 in Solid Tumors with Rezatapopt – NEJM Group

17 days / oncodaily

Florent Peyraud: Restoring Function to a Variant of p53 in Solid Tumors

17 days / oncodaily

Aydah AlAwadhi: Targeting the “Undruggable” p53 – A Long Awaited Proof of Principle

17 days / oncodaily

Monday, March 2, 2026, 2:22 am / permalink 19973 / 9 stories in 14 days

Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

Lei Lei Wu / endpoints - Atrium Therapeutics launched Friday morning as Novartis closed the $12 billion deal to buy Avidity Biosciences and its RNA muscle therapies. The spinout will take on Avidity’s early-stage programs for genetic cardiomyopathies — heart muscle diseases ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance

Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions

15 days / medcitynews / Frank Vinluan

Novartis closes Avidity deal as rare heart disease spinout launches

17 days / endpoints / Lei Lei Wu

Monday, March 2, 2026, 12:23 am / permalink 19968 / 2 stories in 14 days

Health Gorilla Calls Epic Lawsuit ‘Attack on Interoperability’ in Motion to Dismiss / MedCity

Katie Adams / medcitynews - Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ongoing questions about governance and standards for nat…

#healthcare #governmentpolicy #digitalhealth #hospitaloperations

Researchers call for governing health data as a public utility to unlock real-world evidence and protect patients

11 days / medicalxpress

HHS gets serious on information blocking enforcement

11 days / healthcaredive / Sydney Halleman

DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data

15 days / fiercehealthcare

Health Gorilla Calls Epic Lawsuit ‘Attack on Interoperability’ in Motion to Dismiss

15 days / medcitynews / Katie Adams

Health Gorilla urges court to toss lawsuit filed by Epic, health systems

18 days / fiercehealthcare

Health Gorilla files motion to dismiss lawsuit filed by Epic, health systems

18 days / beckershospitalreview / Naomi Diaz

Sunday, March 1, 2026, 6:23 pm / permalink 19963 / 6 stories in 15 days

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity

Katie Adams / medcitynews - About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.The post After 4-Week Strike, Kais…

#healthcare #publichealth #hospitaloperations #healthcarefinance

The Kaiser Settlement Should End the Guesswork in Medicare Advantage Oversight

11 days / medcitynews / David Lareau

2,400 Kaiser mental health workers to hold 1-day strike

11 days / beckershospitalreview / Kelly Gooch

Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer

14 days / beckershospitalreview / Vedant Bhosale

Four Proven Approaches to Stabilizing Clinical Operations

14 days / beckershospitalreview / Vedant Bhosale

Clinician Engagement: The Operating Lever Behind Margin and Throughput

14 days / beckershospitalreview / Vedant Bhosale

Work environment, moral resilience help nurses prevent moral injury

14 days / medicalxpress

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay

19 days / medcitynews / Katie Adams

31,000 Kaiser workers end strike; mental health clinicians back walkout: 6 notes

21 days / beckershospitalreview / Kelly Gooch

Saturday, February 28, 2026, 12:22 pm / permalink 19945 / 8 stories in 16 days

Tag Directory / HEALTHCARE showing 41–60 of 289

CVS Health, Google Cloud to launch healthcare engagement platform / Beckers

New AI tool predicts best pancreatic cancer treatment / Medical Express

FDA lifts hold on Intellia trial / Beckers

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity

FDA vaccine chief to step down in April / Beckers

Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people / Medical Express

AI blood test finds silent liver disease years before symptoms / Science Daily Cancer

Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy / LiveScience

Amazon launches Amazon Connect Health / Beckers

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent Prostate Cancer and PSA of 0.5 ng/mL or Less / ESMO

Novo Nordisk inks $2.1B oral obesity drug deal / Beckers

RFK Jr. names 2 new members to CDC vaccine panel / Beckers

Parents of gravely ill child refused respite care / BBC

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours / ESMO

Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

Health Gorilla Calls Epic Lawsuit ‘Attack on Interoperability’ in Motion to Dismiss / MedCity

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity

HEALTHCARE Heatmap

More Top Stories...

FDA refuses to review Moderna mRNA flu vaccine application

FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

CMS proposes sweeping changes to ACA marketplace plan rules

Tenet forecasts major ACA exchange enrollment drop and financial hit

City of Hope promotes Nisha Morris to senior marketing chief